Enbio provides innovative technology for medical implant surface modification and the application of drugs to such surfaces with the intent of delivering therapy directly to the surgical site leading to improved patient outcomes.

I managed a Fusion technology transfer project between the company and University of Ulster to determine the osteoconductive properties of their process for conveying functionality and drug eluting capability to the surface of metallic implants.

This entry was posted in Client. Bookmark the permalink.